logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9949955 B1

PDFFull Text
Expired
Date of Patent:
Apr. 24, 2018

Filed:

Aug. 04, 2016

Triazolone compounds as mpges-1 inhibitors

Applicant:

Glenmark Pharmaceuticals S.a., La Chaux-de-Fonds, CH;

Inventors:

Laxmikant A. Gharat, Thane (West), IN;

Nagarajan Muthukaman, Erode, IN;

Neelima Khairatkar-Joshi, Thane (W), IN;

Vidya G. Kattige, Thane (W), IN;

Assignee:

GLENMARK PHARMACEUTICALS S.A., La Chaux-de-Fonds, CH;

Attorney:

Blank Rome LLP

Primary Examiner:

Rebecca L Anderson

Assistant Examiner:

Karen Cheng

Int. Cl.
CPC ...
A61K 31/4196 (2006.01); A61K 31/4245 (2006.01); A61K 31/428 (2006.01); A61K 31/433 (2006.01); A61K 31/4439 (2006.01); A61K 31/5377 (2006.01); C07D 249/12 (2006.01); C07D 401/04 (2006.01); C07D 401/10 (2006.01); C07D 403/04 (2006.01); C07D 403/10 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 409/14 (2006.01); C07D 413/10 (2006.01); C07D 413/12 (2006.01); C07D 417/10 (2006.01); C07D 417/12 (2006.01); A61K 31/422 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4196 (2013.01); A61K 31/422 (2013.01); A61K 31/428 (2013.01); A61K 31/4245 (2013.01); A61K 31/433 (2013.01); A61K 31/4439 (2013.01); A61K 31/5377 (2013.01); C07D 249/12 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 403/04 (2013.01); C07D 403/10 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 409/14 (2013.01); C07D 413/10 (2013.01); C07D 413/12 (2013.01); C07D 417/10 (2013.01); C07D 417/12 (2013.01);
Abstract

The present disclosure is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases.

Find Patent Forward Citations

Gharat, Laxmikant. (2018). Triazolone compounds as mpges-1 inhibitors (U.S. Patent No. 9949955). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9949955

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…